Skip to main content
Insights into Imaging
Download PDF
  • Educational Review
  • Open access
  • Published:

Stepwise diagnostic algorithm for high-attenuation pulmonary abnormalities on CT

Insights into Imaging volume 14, Article number: 177 (2023) Cite this article

Abstract

High-attenuation pulmonary abnormalities are commonly seen on CT. These findings are increasingly encountered with the growing number of CT examinations and the wide availability of thin-slice images. The abnormalities include benign lesions, such as infectious granulomatous diseases and metabolic diseases, and malignant tumors, such as lung cancers and metastatic tumors. Due to the wide spectrum of diseases, the proper diagnosis of high-attenuation abnormalities can be challenging. The assessment of these abnormal findings requires scrutiny, and the treatment is imperative. Our proposed stepwise diagnostic algorithm consists of five steps. Step 1: Establish the presence or absence of metallic artifacts. Step 2: Identify associated nodular or mass-like soft tissue components. Step 3: Establish the presence of solitary or multiple lesions if identified in Step 2. Step 4: Ascertain the predominant distribution in the upper or lower lungs if not identified in Step 2. Step 5: Identify the morphological pattern, such as linear, consolidation, nodular, or micronodular if not identified in Step 4. These five steps to diagnosing high-attenuation abnormalities subdivide the lesions into nine categories. This stepwise radiologic diagnostic approach could help to narrow the differential diagnosis for various pulmonary high-attenuation abnormalities and to achieve a precise diagnosis.

Critical relevance statement Our proposed stepwise diagnostic algorithm for high-attenuation pulmonary abnormalities may help to recognize a variety of those high-attenuation findings, to determine whether the associated diseases require further investigation, and to guide appropriate patient management.

Key points

• To provide a stepwise diagnostic approach to high-attenuation pulmonary abnormalities.

• To familiarize radiologists with the varying cause of high-attenuation pulmonary abnormalities.

• To recognize which high-attenuation abnormalities require scrutiny and prompt treatment.

Graphical Abstract

Background

High-attenuation pulmonary abnormalities on CT are often caused by calcification that develops during the healing process of infectious granulomatous diseases. Thus, such abnormalities are usually considered to be non-significant findings. However, they may also be encountered in tumors, metabolic disorders, and occupational diseases. Furthermore, substances other than calcification with high atomic numbers, such as manganese, iron, platinum, barium, iodine, and mercury, also cause high-attenuation pulmonary abnormalities. With the widespread use of thin-slice CT, the frequency of detecting tiny high-attenuation lesions, such as those represented by diffuse pulmonary ossification, and the sensitivity of detecting calcification in lung cancers or metastatic tumors is increasing. Therefore, a wide variety of high-attenuation pulmonary abnormalities on CT may be encountered in daily clinical practice, and identifying the type of lesion can reduce the patients’ burden and healthcare costs related to unnecessary scrutiny and surgery. Further, proper identification allows the clinician to promptly determine whether further examination or the initiation of treatment is needed.

This article aims to outline a stepwise diagnostic approach to high-attenuation pulmonary lesions that can be applied in clinical practice and provide insights into their pathological background. We have defined high-attenuation lesions in the lung in this article as areas that exhibit higher attenuation than the surrounding muscle tissue. Thus, they range from lesions that show faint high attenuation compared to skeletal muscle, such as hematomas, to those that show dense high attenuation, such as barium sulfate. This definition encompasses lesions located in both the lung fields and in the bronchial and pleural cavities, which can sometimes be challenging to differentiate from high-attenuation lesions in the lungs.

Stepwise approach to high-attenuation pulmonary abnormalities

Our proposed stepwise approach consists of five steps in which high-attenuation lesions are classified into nine categories based on the presence or absence of metallic artifacts, morphology, distribution, and concomitant findings. Diseases and findings showing high-attenuation pulmonary abnormalities occupy a broad spectrum of pathologies for which differential diagnosis can be complicated. Take, for example, the differentiation of small granulomatous lesions with calcification from pulmonary ossification. Without knowledge of pulmonary ossification, small high-attenuation lesions in the lower lobes might also be considered granulomatous lesions with calcification. Both are high-attenuation lesions showing linear or micronodular patterns, though pulmonary ossification is primarily predominant in the lower lobes. Therefore, the distinction between both can be made in STEP 4, which highlights the distributional predominance. Following our proposed algorithm, a differential diagnosis can be made even in similar high-attenuation lesions, which can lead to the correct diagnosis.

A summary of the stepwise approach to high-attenuation pulmonary abnormalities is given in Fig. 1. Although some diseases may fall into more than one category, we describe the diseases within the categories in which such lesions are most frequently encountered.

Fig. 1
figure 1

Stepwise diagnostic algorithm for high-attenuation pulmonary abnormalities on CT. Steps 1 to 5 in the flow chart for determining high-attenuation pulmonary abnormalities and the 9 categories of lesions are illustrated. ABPA, allergic bronchopulmonary aspergillosis; EHE, epithelioid hemangioendothelioma; PPFE, pleuroparenchymal fibroelastosis; PSP, pulmonary sclerosing pneumocytoma

Full size image

Thin sections are needed for the imaging evaluation of high-attenuation pulmonary abnormalities on CT. For example, pulmonary ossification is a tiny high-attenuation abnormality; thus, precise assessment requires a gapless scan of 1-mm slice thickness. Furthermore, the optimal assessment of calcification also requires thin sections to minimize volume averaging. Mediastinal window images (e.g., width, 350 HU (Hounsfield unit); level, 60 HU) are suitable for observation to assess mild calcification, whereas bone window (e.g., width, 2500 HU; level, 500 HU) images are suitable for assessing dense calcification, ossification, and metallic substances. Coronal reconstruction is also useful in assessing diseases with a predilection of distribution.

Step 1: Establish the presence or absence of metallic artifacts

Evaluation of high-attenuation pulmonary abnormalities begins with ascertaining whether the lesions on CT scans are associated with metallic artifacts.

Category 1: With metallic artifact

This category comprises abnormalities of non-biological origin, including seed migration, barium sulfate aspiration, and metallic foreign body aspiration.

Seed migration

Low-dose brachytherapy with a permanent implant of I-125 seeds is considered standard therapy for patients with localized prostate adenocarcinoma. Migration of I-125 seeds is reported in approximately 25% of patients and occurs in about 0.5% of cases per I-125 seed [1]. After migrating into the venous plexus around the prostate, I-125 seeds can reach peripheral vessels of various organs due to the contraction of the adjacent bladder [2]. Specifically, they may migrate to the iliac veins, right heart, and lungs [3]. Approximately 80% of migrating I-125 seeds are found in the lungs [1] and are characterized by metallic artifacts (Supplementary Fig. S1). The risk of seed migration was lowest when implants were performed exclusively with stranded seeds compared to those using loose seeds [4].

Barium sulfate aspiration

Discrete high-attenuation lesions are often caused by aspiration of barium sulfate during an upper gastrointestinal study. The involved lung regions depend on the patient’s position during and after aspiration. Thus, the basal segments of the lower lobes are most often involved (Supplementary Fig. S2). After aspiration, most of the barium particles accumulated in alveolar spaces, specifically those with centrilobular distribution, are phagocytosed by alveolar macrophages. However, others may pass directly across the alveolar epithelium into the alveolar or peribronchiolar interstitial tissue. Some particles are transported via lymphatics in the interlobular septa and to the pleura, whereas others remain in the interstitial tissue. Fibrosis may also occur in areas with residual barium [5]. Although barium is generally non-irritating, simultaneous aspiration of gastric acid, anaphylactic reactions, and massive aspiration can lead to severe hypoxia, acute respiratory distress syndrome (ARDS), and even death [6, 7].

Metallic foreign body aspiration

Representative inhaled metallic foreign bodies are pins, screws, and dental prostheses [8, 9]. In adults, due to the vertical orientation of the right main bronchus, the most common location for a foreign body in the airway is the right bronchial tree, particularly in the right lower lobe and bronchus intermedius (Supplementary Fig. S3) [8].

Step 2: Identify associated nodular or mass-like soft tissue components

For lesions without associated metallic artifacts, perform Step 2 to identify whether the high-attenuation lesions are associated with nodular or mass-like soft tissue-attenuation components. If so, skip to Step 3; otherwise, skip to Step 4.

Step 3: Establish the presence of solitary or multiple lesions

This step is performed to identify whether solitary or multiple nodular or mass-like components accompanied by high-attenuation lesions are present.

Category 2: Solitary nodular or mass-like component

Tumors and granulomas are often present in the background.

Primary lung cancer

Calcification is identified in 6–10% of lung cancers, although it does not predict histologic subtype and tends to occur in large tumors [10, 11]. Several mechanisms of calcification in lung cancers have been proposed: engulfment of calcific scar tissue or granulomatous disease, degenerated bronchial cartilage, dystrophic calcification in areas of tumor necrosis, and the secretory function of the carcinoma itself. Calcification may also develop as a sequela of chemotherapy [10, 12]. Furthermore, immune checkpoint inhibitor therapy may cause calcification within the tumor due to drug-induced tumor necrosis [13]. Calcification occurs with amorphous, punctate, or reticular patterns (Fig. 2). Although rare, heterotopic ossification within lung carcinoma may also be present (Fig. 3) [14, 15].

Fig. 2
figure 2

Invasive adenocarcinoma in a 70-year-old man. a CT image shows a right upper lobe mass with eccentric punctate and amorphous calcification (arrows). b Photomicrograph (H-E stain) shows invasive adenocarcinoma with extensive necrosis and calcification (arrows)

Full size image
Fig. 3
figure 3

Invasive adenocarcinoma with stromal ossification in a 69-year-old man. a CT image shows a right upper lobe mass adjacent to the emphysematous cysts. b Mediastinal window image reveals punctate and amorphous calcification or ossification in the mass (arrows). c Photomicrograph (original magnification, × 5.6; H-E stain) shows invasive adenocarcinoma with stromal ossification (arrows)

Full size image

Carcinoid tumor

Bronchial carcinoids are neuroendocrine tumors that range from low-grade typical carcinoids to more aggressive atypical carcinoids. They comprise only 1–2% of all lung tumors and arise in the bronchial and bronchiolar epithelium. Carcinoids may calcify diffusely, and eccentric calcifications are common with foci of calcification or even ossification seen at histologic analysis in up to 30% of cases, particularly in central carcinoids [16].

Pulmonary sclerosing pneumocytoma

Pulmonary sclerosing pneumocytoma (PSP), formerly known as pulmonary sclerosing hemangioma, is a relatively rare, slow-growing, benign tumor that develops in middle-aged women. Although PSP generally presents as a solitary well-defined nodule, multiple nodules may also occur [17]. PSP appears as a well-defined mass with good contrast enhancement ranging from 96 to 157 HU. In addition, the lesion may harbor high-, iso-, and low-attenuation areas that correspond to the tumor’s angiomatous, solid/sclerotic, and cystic components [18].

Calcification has been reported in 41% of PSP on microscopic examination [19]. However, the frequency of calcification on CT is less frequent than that in pathology, with seven reports of calcification among 46 cases [20]. Furthermore, Chung et al. reported that 30% of PSP nodules on CT contained an intratumoral calcification, all of which were stippled (Fig. 4) [21].

Fig. 4
figure 4

Pulmonary sclerosing pneumocytoma in a 25-year-old woman. CT image shows punctate calcifications within the large nodule (arrow)

Full size image

Hamartoma

Pulmonary hamartoma is the most common mesenchymal tumor of the respiratory system, accounting for more than 75% of all benign lung tumors. Furthermore, hamartoma comprises varying amounts of at least two mesenchymal elements, including cartilage, fat, connective tissue, and smooth muscle, combined with respiratory epithelium.

On high-resolution CT (HRCT), fat is identified in 34–50% of pulmonary hamartoma and calcification in 15–30%. The frequency of calcification increases with tumor size [12]. Calcification of pulmonary hamartomas, which results from the calcification of cartilage, can be punctate or conglomerate (Supplementary Fig. S4) [22]. Popcorn calcification is classically described as a CT finding of hamartoma, although it is seen infrequently [23].

Category 3: Multiple nodular or mass-like components

Granulomatous diseases are the most prevalent. However, tumors, such as multiple lung metastases and epithelioid hemangioendothelioma (EHE), may also develop. Amyloidosis is also an important differential diagnosis.

Metastatic tumor

Calcification or ossification commonly occurs with metastatic osteosarcoma and chondrosarcoma. In addition, metastatic carcinomas of the colon (Fig. 5), ovary, breast, and thyroid (Supplementary Fig. S5), and metastatic synovial sarcoma and giant cell tumors of the bone, may calcify. Several mechanisms are responsible for calcification: first, bone formation in osteosarcoma or chondrosarcoma; second, dystrophic calcification in papillary carcinoma of the thyroid, giant cell tumor of the bone, synovial sarcoma, or treated metastatic tumor; and third, mucoid calcification in mucinous adenocarcinoma of the gastrointestinal tract and breast [24]. Calcification may persist following successful chemotherapy despite resolution of the tumor [13].

Fig. 5
figure 5

Metastatic colorectal cancer in a 61-year-old woman. CT image shows soft tissue masses with multiple punctate calcifications in the left lower lobe (arrows)

Full size image

Epithelioid hemangioendothelioma

EHE is a rare tumor of vascular origin, which presents an intermediate clinical course between hemangioma and angiosarcoma. Multiple small nodular pattern (< 15 mm in diameter) and multiple large nodular pattern (≥ 15 mm in diameter) were observed in 71.4% and 22.9% of patients, respectively. However, 5.7% of EHE showed a solitary lesion and may mimic lung cancer [25]. EHE was located predominantly subpleurally with a perivascular location, and 48% of the nodules/masses showed punctate calcification [26]. Extra-pulmonary EHE lesion were observed in 62.9% of cases, with most lesions occurring in the liver. Even with multiple nodules, the patient is expected to have a good prognosis and may not need urgent treatment. Furthermore, spontaneous regression may also occur [25].

Pulmonary hyalinizing granuloma

Pulmonary hyalinizing granuloma (PHG) is a rare benign lung disease that presents as single or multiple lung nodules. The exact etiology is still unknown, although it is hypothesized to be an exaggerated immune response to antigenic stimuli caused by infection or an autoimmune process [27]. PHG is also related to other fibro-sclerosing conditions such as retroperitoneal fibrosis, sclerosing mediastinitis, and sclerosing cholangitis, which are part of the spectrum of IgG4-related sclerosing disease [28].

The nodular lesions of PHG are classically described as well-defined solitary or multiple pulmonary nodules or masses. They may have irregular margins without preference for any particular parenchymal location. In their review, Lhote et al. reported that calcification was found in 6 of 138 cases (4%). Most of the PHG nodules or masses were between 1.5 and 5 cm in size (Fig. 6) [29]. There have been reports of cyst and cavity formation, which could be caused by ischemic necrosis [30].

Fig. 6
figure 6

Pulmonary hyalinizing granuloma in a 47-year-old man. a CT image shows multiple bilateral irregular well-circumscribed nodules. Cyst formation is also seen. b Bone window image shows calcification in the nodules (arrows)

Full size image

Allergic bronchopulmonary aspergillosis

Allergic bronchopulmonary aspergillosis (ABPA) is an immunological lung disorder caused by hypersensitivity to Aspergillus fumigatus. An allergic reaction to Aspergillus antigens is responsible for a local inflammatory reaction, such as infiltration of eosinophils, excessive mucus production, and bronchial wall damage.

Typically, CT reveals central bronchiectasis, usually involving segmental or subsegmental bronchi, with upper lobe predominance [31]. Bronchiectasis filled by mucoid impactions with an inversed Y or V shape is called finger-in-glove opacity [32]. High-attenuation mucus, characterized by higher attenuation than paraspinal muscles, is a pathognomonic finding of ABPA and can be seen in up to 20% of patients (Fig. 7) [33]. The cause of high-attenuation is explained by the presence of calcium salts and even metals, such as ions of iron and manganese, or desiccated mucus [31]. Furthermore, species of Aspergillus other than A. fumigatus and other filamentous fungi can cause similar pathologies called allergic bronchopulmonary mycosis [34], which is also characterized by a high-attenuation mucus plug [35].

Fig. 7
figure 7

Allergic bronchopulmonary aspergillosis in a 62-year-old man. CT image shows high-attenuation mucus plugs in the left upper lobe (arrows)

Full size image

Amyloidosis

Amyloidosis is a group of diseases resulting from the extracellular accumulation of abnormal protein in tissues and organs throughout the body. Three major subtypes of pulmonary involvement have been described: tracheobronchial, nodular parenchymal, and diffuse alveolar septal [36]. We provide an overview of nodular parenchymal and diffuse alveolar septal amyloidosis in this category, and a case of tracheobronchial amyloidosis is shown in Category 6.

Nodular parenchymal amyloidosis may manifest as solitary or multiple pulmonary nodules and mimic various diseases, from granulomatous disease to malignancy. Solitary tumor-like deposits, termed amyloidoma in the absence of systemic disease, are present in 60% of patients. Multiple pulmonary nodules are common and may exhibit smooth, lobulated, or spiculated margins [37], and calcification or ossification is seen in up to 50% of cases (Supplementary Fig. S6) [38, 39]. Alveolar septal pulmonary amyloidosis is characterized by well-defined 2–4-mm scattered micronodules accompanied by reticular opacities, interlobar septal thickening, and confluent consolidations with a basal and peripheral predominance [37].

In addition, the cysts may also be associated with calcified or noncalcified soft-tissue nodules. Nodular amyloidosis associated with thin-walled cysts is most common in patients with Sjögren syndrome. However, whether the cysts manifest lymphocytic interstitial pneumonia as a result of Sjögren syndrome or are a manifestation of amyloidosis, possibly due to small airway obstruction by amyloid deposits, is unclear [37, 40].

Silicosis

The inhalation of dust containing silica causes silicosis. It occurs in two distinct forms: acute silicosis, also known as silicoproteinosis, and classic or chronic silicosis, with the development of nodular infiltrative lung disease. Silicoproteinosis is a rare disease that can cause the rapid onset of respiratory failure following massive exposure to silica dust. Foci of calcification within areas of consolidation were seen in 83% of patients [41]. Classic or chronic silicosis typically manifests after 10 to 20 years of exposure to low concentrations of silica dust, with classic silicosis leading to lung fibrosis. The direct cytotoxic effects of silica cause macrophage death, followed by the release of inflammatory cytokines and other substances, and induce fibroblast proliferation [42].

Classic silicosis has two forms, simple and complicated, according to the radiographic findings. Simple silicosis is characterized on CT by the presence of multiple small nodules 2–5 mm in diameter with calcification. The nodules may be distributed diffusely throughout both lungs, but they tend to be most numerous in the upper lobes. On thin-section CT images, nodules are usually observed in centrilobular, paraseptal, and subpleural regions and show a perilymphatic distribution. Small nodular or branching centrilobular opacities may be an early sign of silicosis (Supplementary Fig. S7) [43]. Complicated silicosis, also termed progressive massive fibrosis, develops through the expansion and confluence of individual silicotic nodules. The most prominent HRCT finding of complicated silicosis is the development of large irregular nodules or masses or mass-like consolidation associated with apical scarring, distortion of lung architecture, and the development of adjacent bullae. These masses often develop in the middle portion or periphery of the upper lung zones and migrate toward the hila over time (Fig. 8). Calcification within conglomerate masses is also common [42]. Calcification of lymph nodes is common and typically occurs at the periphery of the node, termed eggshell calcification, which is characteristic, but punctate calcification has been reported as being more frequent [43].

Fig. 8
figure 8

Silicosis (complicated form) in a 77-year-old man. a CT image shows a conglomerate mass, progressive massive fibrosis (PMF), in the right upper and lower lobes that crosses the major fissure. b Punctate and nodular calcifications are seen in the PMF. Mediastinal and hilar lymph nodes are also calcified (arrows)

Full size image

Step 4: Ascertain the predominant distribution in the upper or lower lungs

For Step 4, high-attenuation lesions without nodular or mass-like components can be further categorized into two groups, those in the upper and lower lungs, according to the presence of their predominant distribution.

Category 4: Upper lungs predominance

Metastatic calcification and pleuroparenchymal fibroelastosis (PPFE)-like lesion are included.

Metastatic calcification

Metastatic calcification is calcium deposition in normal lung tissue without prior tissue damage and is related to chronically elevated serum calcium phosphate product. The most common cause of metastatic calcification is hemodialysis for chronic renal insufficiency. Its prevalence in an unselected population was relatively low: only 14 cases (0.2%) of metastatic calcification were identified in a retrospective review of over 7000 autopsies [44]. In contrast, metastatic pulmonary calcification was found in 60–75% of hemodialyzed patients at autopsy [45, 46]. Calcium salts precipitate in an alkaline environment. The secretion of free hydrogen ions is an important local factor in developing metastatic calcification. The lungs, stomach, and kidneys secrete free hydrogens ions, resulting in an alkaline tissue environment. Furthermore, the pH of the blood in the lung is more alkalotic than that in other organs due to CO2 removal. Thus, the upper lobe predilection of pulmonary calcific disorders is explained by a higher blood pH and lower PaCO2 at the apex compared with the relatively lower pH at the base (Fig. 9). This difference is accounted for by the higher ventilation-perfusion ratio at the lung apex compared with the base [47].

Fig. 9
figure 9

Metastatic calcification in a 61-year-old man. a CT image shows mass-like opacities containing dense calcification in the bilateral upper lobes. b Coronal CT image reveals that calcification is predominantly distributed in the upper lobes

Full size image

Radiologically, three patterns are identified: diffuse or patchy areas of ground-glass opacity or consolidation, multiple diffuse calcified nodules, and confluent high-attenuation consolidation with a predominantly lobar distribution (Supplementary Figs. S8 and S9) [48, 49]. Further, numerous fluffy and poorly defined nodules measuring 3–10 mm in diameter, with centrilobular ground-glass opacities, are also typical findings [50]. However, if the amount of calcium salts deposition is not high, such nodules may not be recognized as a high-attenuation lesion in mediastinal windows. Therefore, ground-glass opacity seen in lung windows may also reflect calcification. Only a micronodular or nodular high-attenuation lesion, corresponding to part of the lesion of metastatic calcification, may be identified in the mediastinal windows. In addition, calcification is often present in the vessels of the chest wall on CT scans (Supplementary Fig. S9) [48]. Pathologically metastatic calcification is characterized by strong hematoxylin staining in the alveolar space, alveolar septa, and the walls of small pulmonary vessels and bronchi (Fig. 10) [51].

Fig. 10
figure 10

Metastatic calcification in a 70-year-old woman. a CT image shows poorly defined nodular opacities in the right upper lobe (arrows). b Photomicrograph (H-E stain) reveals calcification around respiratory bronchioles (arrows). RB, respiratory bronchiole

Full size image

Pleuroparenchymal fibroelastosis-like lesion

PPFE-like lesion presents as dense subpleural consolidation associated with the evidence of fibrosis in the upper lobe without differentiation between PPFE and the apical cap. According to Sumikawa et al., PPFE-like lesion was observed in 397 of 1284 patients (30.9%). In that study, old tuberculosis (TB) and chronic airway diseases strongly correlated with the presence of PPFE-like lesion, indicating that repeated inflammatory damage might cause such a lesion [52]. Small calcified nodules with soft tissue attenuation can be identified on CT (Supplementary Fig. S10).

Category 5: Lower lungs predominance

This category includes pulmonary alveolar microlithiasis, pulmonary ossification, lipiodol embolism, talc pleurodesis, and thoracolithiasis.

Pulmonary alveolar microlithiasis

Pulmonary alveolar microlithiasis is a rare autosomal recessive disease. The mutation of the SLC34A2 gene prevents the movement of phosphorus ions from the alveolar spaces into type II pneumocytes, thus leading to the formation of calcium phosphate microliths in the alveolar spaces [53]. The microliths are round or ovoid with a concentric lamellated appearance and range from 0.01 to 2.8 mm in diameter [54].

The most common findings on HRCT are diffuse ground-glass opacities and small calcified parenchymal nodules, which preferentially involve the posterior, inferior, and central regions of the lungs. Other CT features include calcifications along the interlobular septa, bronchovascular bundles, fissures, and pleura (Fig. 11). Dense areas of consolidation and subpleural cysts that represent dilated alveolar ducts [55] may also be identified. The small calculi within the alveolar spaces result in diffuse ground-glass opacities, and the presence of high-attenuation micronodules is called “sandstorm appearance”. In addition, calcifications along the interlobular septa lead to linear opacity, and these calculi can converge to form larger parenchymal nodules or more confluent consolidations.

Fig. 11
figure 11

Pulmonary alveolar microlithiasis in a 39-year-old woman. a CT image shows extensive calcification with interlobular septa predominance. b Photomicrograph (original magnification, × 8; decalcified H-E stain) reveals concentrically lamellated calcified bodies in the intra-alveolar spaces (arrowheads)

Full size image

Pulmonary ossification

Pulmonary ossification is a rare condition that consists of bone formation in the alveolar spaces. Although the exact definition has not yet been established, widespread or extensive pulmonary ossification is called diffuse pulmonary ossification (DPO). According to autopsy examinations, the incidence of DPO is 1.63 in 1000 cases [56]. Pulmonary ossification can be idiopathic (Fig. 12) or secondary, resulting from conditions such as pulmonary congestion (particularly with mitral stenosis), aspiration, severe lung injury (Supplementary Fig. S11), and fibrosing interstitial lung disease (Fig. 13) [57,58,59]. Morphologically, pulmonary ossification is classified into two subtypes: dendriform and nodular type. Idiopathic cases are basically dendriform and show branching structures on CT [60]. Secondary cases can be both, and those associated with interstitial lung disease often appear as tiny nodules on imaging, even if they are dendriform on histopathology, making morphological separation difficult. Bony spines are considered to cause a rupture of the elastic fiber layer of the visceral pleura, which may lead to pneumothorax [61].

Fig. 12
figure 12

Idiopathic dendriform pulmonary ossification in a 76-year-old man. a CT image shows tiny contiguous branching nodules in the subpleural lesion of the right lower lobe (arrows). b Bone window image shows high attenuating small nodules (arrows). c Photomicrograph (H-E stain) reveals multiple bone formations in the alveolar ducts and alveoli (arrows). Br, bronchiole; PA, pulmonary artery; PV, pulmonary vein

Full size image
Fig. 13
figure 13

Secondary diffuse pulmonary ossification associated with systemic sclerosis-related interstitial lung disease in a 65-year-old woman. a CT image shows reticulation with cystic formation in the peripheral and bilateral lower lobes. b Bone window image shows high-attenuation nodules in the area of reticulation (arrows). c Photomicrograph (H-E stain) shows the tiny focus of ossification in the subpleural fibrotic lesion (arrow)

Full size image

The distribution of pulmonary ossification is predominantly in the lower lobe, with a predilection for the posterior and lateral basilar segments and lung bases. The posterior aspect of the upper lobes may also be involved; however, ossification in this area always occurs in the presence of concomitant lower lobe diseases [62]. Egashira et al. also reported that DPO associated with fibrosing interstitial lung disease was present in the peripheral lung, especially in areas of reticulation [57]. High attenuation, reflecting underlying ossification, can be identified in some but not all nodules. Thin-section and volume-rendering CT images are helpful in the detection of small high-attenuation foci (Supplementary Fig. S12) [62]. The use of bone windows rather than mediastinal windows makes multiple tiny ossifications easier to identify.

Lipiodol embolism

Lipiodol is an ethyl ester of iodized fatty acids of poppy seed oil. Approximately 2% of patients who underwent percutaneous transcatheter arterial chemoembolization (TACE) developed pulmonary oily embolism. The lesions were found in all cases in the lower lobes [63], which may be due to the proximity to the treatment site of the liver. The risk factors for pulmonary lipiodol embolism after TACE include the dose of the iodized oil, the presence of an arteriovenous shunt, and trans-inferior phrenic artery embolization [64, 65]. ARDS may sometimes develop due to chemical injury caused by free fatty acid components [66]. Pulmonary oily embolisms were revealed within 12 to 48 h after TACE, and imaging abnormalities returned to normal between 12 and 35 days after the procedure [63]. In the early stages of the disease, in addition to deposits of high-attenuation lipiodol, the lung window shows ground-glass opacity reflecting hemorrhage resulting from lipiodol-induced infarction. Subsequently, phagocytosis by macrophages and lymphatic drainage may cause the lesions to shrink or resolve (Fig. 14).

Fig. 14
figure 14

Pulmonary lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma in a 54-year-old woman. a A shunt between the right inferior phrenic artery and the hepatic vein (arrow) was revealed during chemoembolization with lipiodol. b Postoperative CT image shows a high-attenuation lesion in the right lower lobe, which is compatible with the accumulation of lipiodol. c Three months later, the dense lesion was smaller and had changed into a linear-like opacity (arrow)

Full size image

Talc pleurodesis

Talc is a sclerosing agent for pleural adhesions and has been used in managing patients with benign and malignant pleural effusions and spontaneous pneumothorax. The presence of high-attenuation areas in the posterior basal regions of the pleural space is a typical finding after talc administration. However, it should be differentiated from findings of previous asbestos exposure, healed empyema, and TB. Talc deposits in the interlobar fissures with associated thickening of the fissure, which can possibly be mistaken for a calcified lung nodule, may also be encountered (Fig. 15) [67].

Fig. 15
figure 15

Talc pleurodesis in an 81-year-old woman. a, b CT images show a nodular high-attenuation talc deposit in the interlobar fissure (arrow)

Full size image

Thoracolithiasis

Thoracolithiasis is an entity in which one or more calcified or non-calcified loose bodies move freely in the thoracic cavity without any preceding trauma, intervention, or pleurisy. The prevalence of thoracolithiasis is approximately 0.086%. Thoracolithiasis usually manifests as a single calcified nodule and tends to occur in the left hemithorax. Most thoracoliths are located in the lower part of the pleural cavity, notably below the level of the top of each hemidiaphragm dome, which may be due to the effect of gravity. The longest diameter of thoracoliths ranges from 2.1 to 10.6 mm, and they all show calcification with an oval or round-shape. Because of the continuous movement associated with breathing, thoracoliths can become rounded and polished. Based on the presence of a necrotic fatty core in most thoracoliths and their left-sided predominance, dropping of twisted or torn epipericardial fat undergoing aseptic necrosis seems to be the most explainable etiology. As the mobility of the nodule is the critical finding in the diagnosis, comparison with older imaging studies is crucial (Supplementary Fig. S13) [68].

Step 5: Identify the morphological pattern: linear, consolidation, nodular, or micronodular

If there is no distributional predominance, Step 5 is the final step. High-attenuation abnormalities are classified into linear, consolidation, nodular, or micronodular pattern according to morphological characteristics.

Category 6: Linear pattern

Linear high-attenuation lesions include staple line, tracheobronchial calcification, and granulomatous infection. Among these lesions, staple line is often difficult to distinguish from granulomatous infection, and tracheobronchial calcification may be misdiagnosed as calcified lesions of non-bronchial origin.

Tracheobronchial calcification

Calcification of tracheobronchial cartilage has been recognized as an age-related phenomenon that occurs almost exclusively in patients over 40 years old. Compared to age-matched control subjects, an increased incidence of tracheobronchial calcification in adults receiving warfarin sodium was present. Several case reports of tracheobronchial calcification in pediatric patients with a history of postoperative cardiac surgery have also been published (Fig. 16) [69,70,71]. Warfarin is thought to be responsible for forming tracheobronchial calcification based on the hypothesis that warfarin inhibits the normal formation of a vitamin K-dependent protein that prevents calcification of cartilage and connective tissue [72].

Fig. 16
figure 16

Tracheobronchial calcification associated with long-term warfarin therapy after pulmonary artery banding and ligation of patent ductus arteriosus in a 27-year-old man. Bone window CT image shows that calcifications can be identified along the bronchi (arrows)

Full size image

Tracheobronchial calcification may also occur in tracheobronchopathia osteochondroplastica, relapsing polychondritis, and tracheobronchial amyloidosis (Supplementary Fig. S14) accompanied by wall thickening. Tracheobronchopathia osteochondroplastica and relapsing polychondritis spare the posterior membranous wall and affect only the cartilaginous portion. In tracheobronchial amyloidosis, however, involvement is circumferential, thus affecting the posterior membranous wall as well [73].

Staple line

In recent years, surgical staples, commonly made from titanium [74], have come into widespread use in thoracic surgery, especially in video-assisted thoracic surgery. Surgical staples are depicted as high-attenuation linear opacities. Nevertheless, in the case of partial resection of a lung lobe, the resection margin of the bronchus may not be identifiable, making it difficult to determine that it is a postoperative change. In addition, in cases of postoperative changes such as minor collapse or post-inflammatory scarring around the staple line, it is difficult to distinguish staple lines from calcified lesions, including old pulmonary TB, which presents as linear high-attenuation lesions. Furthermore, although surgical staples are metallic, their sizes are small and they often do not present as metallic artifacts, making them difficult to identify as staple lines. However, staple lines are depicted as a continuous, linear, high-attenuation structure always attached to the pleura. Besides, a linear structure can be differentiated from other diseases by the presence of a continuous high-attenuation nodular opacity, which corresponds to the surgical staples (Supplementary Fig. S15).

Category 7: Consolidation pattern

Amiodarone pulmonary toxicity and metastatic calcification may show high-attenuation consolidation. However, metastatic calcification is found predominantly in the upper lungs and is therefore described in Category 4.

Amiodarone pulmonary toxicity

Amiodarone, an anti-arrhythmic agent for refractory tachyarrhythmias, contains 37.3% iodine by weight. This high iodine content makes possible the detection of amiodarone deposits in the lung by CT [75]. The risk is highest in the first 6 to 12 months of treatment, and the frequency of onset increases as the cumulative dose increases from 101 to 150 g. Amiodarone and its metabolites accumulate in macrophages and type II pneumocytes in the lungs. Due to the very long half-life of amiodarone, the CT attenuation value increases. In roughly 90% of cases, elevated liver and spleen concentrations are also found, which can be identified through the lung bases on chest CT.

The HRCT findings of amiodarone lung include ground-glass opacities, focal or diffuse areas of consolidation, and reticular opacities. However, the unique feature of amiodarone-related lung toxicity is the presence of foci of attenuation greater than that of the soft tissue due to tissue accumulation of this iodinated compound (Fig. 17) [76].

Fig. 17
figure 17

Amiodarone pulmonary toxicity in an 85-year-old woman. a CT image shows an extensive area of consolidation in the left upper lobe. b Mediastinal window image shows consolidation with high attenuation. c The liver shows increased attenuation, which is compatible with amiodarone deposition

Full size image

Category 8: Nodular pattern

As the Nomenclature Committee of the Fleischner Society has recommended that the term micronodule should be used to refer to nodules of less than 3 mm in diameter [77], we use the term “nodular pattern” to apply to cases that often show high-attenuation nodules of 3 mm or larger. Nodular pattern occurs in three distinct diseases: granulomatous infection, broncholithiasis, and hematoma. However, there may be overlaps between micronodular patterns, especially with granulomatous infection. The absorption process of a hematoma due to pulmonary laceration may also fit this pattern, although the finding may change and eventually resolve.

Granulomatous infection

Microbial infections that elicit a granulomatous tissue response can also result in a variety of thoracic dystrophic calcifications [47]. TB is a common cause of intrathoracic calcifications, especially in Asia and Africa. Apical and posterior segments of the upper lobes and superior segments of the lower lobes are often involved because of the high ventilation-perfusion ratio and decreased lymphatic drainage. As dystrophic calcifications are the sequelae of infection, patients with a prior infection are more common than those with newly diagnosed active disease. Therefore, CT findings of distortion of bronchovascular structures, bronchiectasis, emphysema, and fibrotic bands are frequently seen with calcification. Calcification shows numerous patterns related to fibrosis and granulomatous tissue, such as linear, nodular, micronodular, or even with nodular or mass-like soft tissue-attenuation components (Supplementary Figs. S16 and S17). The Ghon focus, a primary lesion of Mycobacterium tuberculosis, usually heals through development of a fibrous capsule around the focus of infection, which may show tiny calcification (Supplementary Fig. S18). Calcification of tuberculoma, a round or oval granuloma with a wall lined by granulomatous inflammatory tissue or encapsulated by connective tissue, is found in 20 to 30% of patients [78] and may show coarse calcification. Soft tissue attenuation can be accompanied by calcification, which is related to caseous necrotic material. In addition, when caseous necrosis occurs, robust phosphatase activity can take place within the necrotic centers, and subsequently, calcification is invariably found in the phosphatase-positive areas [47].

Other granulomatous infections can also cause calcification. Histoplasmomas may show numerous small and diffuse calcified pulmonary nodules. Although uncommon, coccidiomycosis may result in single or multiple dystrophic calcified nodules [47]. Further, diffuse, dense calcifications of 2 to 3 mm may occur in otherwise normal lungs as a sequela of varicella pneumonia [79].

Broncholithiasis

Broncholithiasis is defined as calcified or ossified material (broncholith) within the tracheobronchial tree and can be referred to as endobronchial, peribronchial, or transbronchial. Any focal process that results in dystrophic calcification can potentially lead to broncholithiasis. The most well-known theory of broncholithiasis is that necrotizing granulomas within the lymph nodes calcify and erode the bronchial wall, protruding into the tracheobronchial tree. In addition, necrotizing granulomas of TB can leak into the airway to facilitate transmission of the bacilli as a survival mechanism [80]. Further, mucus is a known cause of the endobronchial origin of broncholiths, and bronchiectasis is frequently reported as an underlying disease (Supplementary Fig. S19) [81].

The incidence of broncholiths was highest in the bronchus intermedius, followed by the left upper lobe and right upper lobe (Supplementary Fig. S20) [80]. Due to the anatomy of the airway and the distribution of the lymph nodes, broncholiths tend to occur more on the right side, especially in the upper and middle lobes [82]. Long-standing airway obstruction may lead to bronchiectasis, and air trapping and lobar or segmental atelectasis or consolidation may also occur. Endobronchial actinomycosis associated with broncholiths has also been reported [83].

Hematoma

Intrapulmonary hematomas are often present in the course of traumatic pulmonary lacerations. In the early stages of injury, a high-attenuation air-fluid level (hematopneumatocele) is characteristic. Subsequently, lacerations can take weeks to months to resolve as the air inside the laceration is gradually absorbed, eventually turning into a hematoma presenting as a solid, homogeneous, high-attenuation mass (Fig. 18). Hematomas have been found to shrink less than 0.5 cm in 3 weeks, but finally, the hematoma becomes a small fibrous nodule. The time to resolution of hematomas observed on imaging varies: while most resolve gradually within 5 weeks, some can take up to a year to resolve after injury [84].

Fig. 18
figure 18

Pulmonary laceration due to traumatic injuries in a 28-year-old man. a CT image shows a high-attenuation air-fluid level in the right lower lobe (arrows). b The lacerated cyst has decreased in size, and the air bubble has been absorbed (arrows). c Although the air bubble has disappeared, the attenuation of the nodule remains high (arrows). d Attenuation of the nodule has decreased, and subsequent shrinkage of the nodule is shown (arrows)

Full size image

Ehlers-Danlos syndrome subtype IV may cause spontaneous pulmonary laceration because of a defect of type III collagen. Following laceration, bleeding from disrupted alveolar walls and pulmonary vasculature results in the formation of hematoma [85].

Category 9: Micronodular pattern

Micronodular pattern is characterized by calcified nodules of less than 3 mm in diameter that result from granulomatous infection and cement migration.

Cement migration

Percutaneous vertebroplasty with acrylic cement (polymethyl methacrylate; PMMA) aims to prevent vertebral body collapse and pain in patients with pathologic vertebral bodies. As chest imaging is not routinely performed after this procedure, the true incidence of pulmonary cement embolism after percutaneous vertebroplasty is unknown. However, some studies reported an incidence of pulmonary cement embolism detected by chest radiograph and CT ranging from 4.6 to 6.8% [86, 87]. Venous leaks of PMMA significantly increase the risk of PMMA pulmonary emboli for the following reasons: the liquid consistency of the PMMA, the treatment of some malignant lesions in which more frequent cortical destruction of the vertebral body occurs, and high vascularity associated with some malignant tumors [86]. Solitary or multiple tubular or branching high-attenuation cement deposits within the pulmonary vessels are identified on CT (Supplementary Fig. S21).

Limitations

The proposed diagnostic algorithm has limitations. First, there may be more than one category for the same disease. Second, diseases that are likely to be encountered in daily clinical practice were eligible for inclusion in this algorithm. Therefore, rare diseases, such as extramedullary plasmacytoma [88], synovial sarcoma [89], and hemosiderosis [12, 90] presenting with calcification, are not included. Despite these limitations, our proposed diagnostic algorithm is presented with a focus on diseases and patterns that are likely to be encountered in everyday clinical practice and provides a concise algorithmic method that can be practically useful for the differential diagnosis of high-attenuation pulmonary abnormalities.

Conclusions

High-attenuation pulmonary abnormalities are caused by calcification, ossification, hemorrhage, iodine, and other etiologies. The majority of these abnormalities, such as granulomatous infections, are benign. However, they are also recognized in malignant diseases including lung cancers and metastatic tumors and can lead to a wide range of differential diagnoses. Some of these attenuations, such as hematomas and lipiodol embolisms, may change their morphology and characteristics over a relatively short time. Our proposed stepwise diagnostic algorithm for high-attenuation pulmonary abnormalities may help to recognize these imaging findings, to determine whether the associated diseases require further investigation, and to guide appropriate patient management.

Availability of data and materials

Not applicable.

Abbreviations

ABPA:

Allergic bronchopulmonary aspergillosis

ARDS:

Acute respiratory distress syndrome

DPO:

Diffuse pulmonary ossification

EHE:

Epithelioid hemangioendothelioma

HRCT:

High-resolution computed tomography

HU:

Hounsfield unit

PHG:

Pulmonary hyalinizing granuloma

PMMA:

Polymethyl methacrylate

PPFE:

Pleuroparenchymal fibroelastosis

PSP:

Pulmonary sclerosing pneumocytoma

TACE:

Transcatheter arterial chemoembolization

TB:

Tuberculosis

References

  1. Sugawara A, Nakashima J, Kunieda E et al (2011) Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds. Radiat Oncol 6:130

    PubMed  PubMed Central  Google Scholar 

  2. Maletzki P, Schwab C, Markart P et al (2018) Late seed migration after prostate brachytherapy with Iod-125 permanent implants. Prostate Int 6:66–70

    PubMed  Google Scholar 

  3. Nakano M, Uno H, Gotoh T et al (2006) Migration of prostate brachytherapy seeds to the vertebral venous plexus. Brachytherapy 5:127–130

    PubMed  Google Scholar 

  4. Merrell KW, Davis BJ, Goulet CC et al (2019) Reducing seed migration to near zero with stranded-seed implants: comparison of seed migration rates to the chest in 1000 permanent prostate brachytherapy patients undergoing implants with loose or stranded seeds. Brachytherapy 18:306–312

    PubMed  Google Scholar 

  5. Voloudaki A, Ergazakis N, Gourtsoyiannis N (2003) Late changes in barium sulfate aspiration: HRCT features. Eur Radiol 13:2226–2229

    CAS  PubMed  Google Scholar 

  6. Hamid M, Ullah W, Ur Rashid M, Amjad W, Mukhtar M, Hurairah A (2018) An esophagogram or tracheobronchogram? A review of barium sulfate aspiration. J Investig Med High Impact Case Rep 6:2324709618802872

    PubMed  PubMed Central  Google Scholar 

  7. Yan GW, Deng JF, Bhetuwal A et al (2017) A case report and literature review of barium sulphate aspiration during upper gastrointestinal examination. Medicine (Baltimore) 96:e8821

    PubMed  Google Scholar 

  8. Sehgal IS, Dhooria S, Ram B et al (2015) Foreign body inhalation in the adult population: experience of 25,998 bronchoscopies and systematic review of the literature. Respir Care 60:1438–1448

    PubMed  Google Scholar 

  9. Hadad H, de Jesus LK, Poli PP, Garcia-Júnior IR, Souza F, de Oliveira FRG (2021) Aspiration of the dental crown in an elderly patient. Radiol Case Rep 16:2280–2285

    PubMed  PubMed Central  Google Scholar 

  10. Mahoney MC, Shipley RT, Corcoran HL, Dickson BA (1990) CT demonstration of calcification in carcinoma of the lung. AJR Am J Roentgenol 154:255–258

    CAS  PubMed  Google Scholar 

  11. Grewal RG, Austin JH (1994) CT demonstration of calcification in carcinoma of the lung. J Comput Assist Tomogr 18:867–871

    CAS  PubMed  Google Scholar 

  12. Khan AN, Al-Jahdali HH, Allen CM, Irion KL, Al Ghanem S, Koteyar SS (2010) The calcified lung nodule: what does it mean? Ann Thorac Med 5:67–79

    PubMed  PubMed Central  Google Scholar 

  13. Sumi T, Uehara H, Masaoka T et al (2020) Lung adenocarcinoma with tumor resolution and dystrophic calcification after salvage surgery following immune checkpoint inhibitor therapy: a case report. Thorac Cancer 11:3396–3400

    PubMed  PubMed Central  Google Scholar 

  14. McLendon RE, Roggli VL, Foster WL Jr, Becsey D (1985) Carcinoma of the lung with osseous stromal metaplasia. Arch Pathol Lab Med 109:1051–1053

    CAS  PubMed  Google Scholar 

  15. Kim GY, Kim J, Kim TS, Han J (2009) Pulmonary adenocarcinoma with heterotopic ossification. J Korean Med Sci 24:504–510

    PubMed  PubMed Central  Google Scholar 

  16. Jeung MY, Gasser B, Gangi A et al (2002) Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings. Radiographics 22:351–365

    PubMed  Google Scholar 

  17. Morikawa K, Misumi S, Fukuda T, Ojiri H, Matsudaira H, Sato S (2019) Pulmonary sclerosing pneumocytoma presenting as slow-growing multiple nodules over a long period. Radiol Case Rep 14:602–607

    PubMed  PubMed Central  Google Scholar 

  18. Im JG, Kim WH, Han MC et al (1994) Sclerosing hemangiomas of the lung and interlobar fissures: CT findings. J Comput Assist Tomogr 18:34–38

    CAS  PubMed  Google Scholar 

  19. Katzenstein AL, Gmelich JT, Carrington CB (1980) Sclerosing hemangioma of the lung: a clinicopathologic study of 51 cases. Am J Surg Pathol 4:343–356

    CAS  PubMed  Google Scholar 

  20. Hu AM, Zhao D, Zheng H, Wang QH, Lyu Y, Li BL (2016) Preoperative diagnosis in 46 cases of pulmonary sclerosing hemangioma. Chin Med J (Engl) 129:1377–1378

    PubMed  Google Scholar 

  21. Chung MJ, Lee KS, Han J, Sung YM, Chong S, Kwon OJ (2006) Pulmonary sclerosing hemangioma presenting as solitary pulmonary nodule: dynamic CT findings and histopathologic comparisons. AJR Am J Roentgenol 187:430–437

    PubMed  Google Scholar 

  22. Webb WR, Higgins CB (2017) Pulmonary hamartoma. In: Thoracic imaging, 3rd edn. Wolters Kluwer, Philadelphia

  23. Siegelman SS, Khouri NF, Scott WW Jr et al (1986) Pulmonary hamartoma: CT findings. Radiology 160:313–317

    CAS  PubMed  Google Scholar 

  24. Seo JB, Im JG, Goo JM, Chung MJ, Kim MY (2001) Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 21:403–417

    CAS  PubMed  Google Scholar 

  25. Onishi Y, Kusumoto M, Goto Y, Kaku S, Motoi N (2020) Epithelioid hemangioendothelioma of the lung: CT findings and clinical course of 35 cases. Jpn J Clin Oncol 50:1195–1200

    PubMed  Google Scholar 

  26. Liu K, Xie P, Peng W, Zhou Z (2014) The computed tomographic findings of pulmonary epithelioid hemangioendothelioma. Radiol Med 119:705–713

    PubMed  Google Scholar 

  27. Engleman P, Liebow AA, Gmelich J, Friedman PJ (1977) Pulmonary hyalinizing granuloma. Am Rev Respir Dis 115:997–1008

    CAS  PubMed  Google Scholar 

  28. Chapman EM, Gown A, Mazziotta R, Churg A (2012) Pulmonary hyalinizing granuloma with associated elevation in serum and tissue IgG4 occurring in a patient with a history of sarcoidosis. Am J Surg Pathol 36:774–778

    PubMed  Google Scholar 

  29. Lhote R, Haroche J, Duron L et al (2017) Pulmonary hyalinizing granuloma: a multicenter study of 5 new cases and review of the 135 cases of the literature. Immunol Res 65:375–385

    PubMed  Google Scholar 

  30. Yousem SA, Hochholzer L (1987) Pulmonary hyalinizing granuloma. Am J Clin Pathol 87:1–6

    CAS  PubMed  Google Scholar 

  31. Chabi ML, Goracci A, Roche N, Paugam A, Lupo A, Revel MP (2015) Pulmonary aspergillosis. Diagn Interv Imaging 96:435–442

    CAS  PubMed  Google Scholar 

  32. Franquet T, Müller NL, Giménez A, Guembe P, de La Torre J, Bagué S (2001) Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 21:825–837

    CAS  PubMed  Google Scholar 

  33. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK (2006) Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 130:442–448

    PubMed  Google Scholar 

  34. Asano K, Hebisawa A, Ishiguro T et al (2021) New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol 147:1261-1268.e1265

    PubMed  Google Scholar 

  35. Kodaka N, Nakano C, Oshio T et al (2022) Effectiveness of mucus plug removal by bronchoscopy for typical high-attenuation mucus with allergic bronchopulmonary mycosis. Allergol Int 71:150–152

    PubMed  Google Scholar 

  36. de Almeida RR, Zanetti G, Pereira ESJL et al (2015) Respiratory tract amyloidosis. State-of-the-art review with a focus on pulmonary involvement. Lung 193:875–883

    PubMed  Google Scholar 

  37. Czeyda-Pommersheim F, Hwang M, Chen SS, Strollo D, Fuhrman C, Bhalla S (2015) Amyloidosis: modern cross-sectional imaging. Radiographics 35:1381–1392

    PubMed  Google Scholar 

  38. Pickford HA, Swensen SJ, Utz JP (1997) Thoracic cross-sectional imaging of amyloidosis. AJR Am J Roentgenol 168:351–355

    CAS  PubMed  Google Scholar 

  39. Lee AY, Godwin JD, Pipavath SN (2012) Case 182: pulmonary amyloidosis. Radiology 263:929–932

    PubMed  Google Scholar 

  40. Ohdama S, Akagawa S, Matsubara O, Yoshizawa Y (1996) Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification. Eur Respir J 9:1569–1571

    CAS  PubMed  Google Scholar 

  41. Marchiori E, Souza CA, Barbassa TG, Escuissato DL, Gasparetto EL, Souza AS Jr (2007) Silicoproteinosis: high-resolution CT findings in 13 patients. AJR Am J Roentgenol 189:1402–1406

    PubMed  Google Scholar 

  42. Desai SR, Lynch DA, Elicker BM, Devaraj A, Sverzellati N (2021) Silicosis. In: High-resolution CT of the lung, 6th edn. Wolters Kluwer, Philadelphia

  43. Antao VC, Pinheiro GA, Terra-Filho M, Kavakama J, Müller NL (2005) High-resolution CT in silicosis: correlation with radiographic findings and functional impairment. J Comput Assist Tomogr 29:350–356

    PubMed  Google Scholar 

  44. Kaltreider HB, Baum GL, Bogaty G, McCoy MD, Tucker M (1969) So-called “metastatic” calcification of the lung. Am J Med 46:188–196

    CAS  PubMed  Google Scholar 

  45. Conger JD, Hammond WS, Alfrey AC, Contiguglia SR, Stanford RE, Huffer WE (1975) Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. Ann Intern Med 83:330–336

    CAS  PubMed  Google Scholar 

  46. Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond WS (1977) Soft tissue calcification in chronic dialysis patients. Am J Pathol 86:403–424

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz MI (2002) Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 165:1654–1669

    PubMed  Google Scholar 

  48. Hartman TE, Müller NL, Primack SL et al (1994) Metastatic pulmonary calcification in patients with hypercalcemia: findings on chest radiographs and CT scans. AJR Am J Roentgenol 162:799–802

    CAS  PubMed  Google Scholar 

  49. Kuhlman JE, Ren H, Hutchins GM, Fishman EK (1989) Fulminant pulmonary calcification complicating renal transplantation: CT demonstration. Radiology 173:459–460

    CAS  PubMed  Google Scholar 

  50. Belém LC, Zanetti G, Souza AS Jr et al (2014) Metastatic pulmonary calcification: state-of-the-art review focused on imaging findings. Respir Med 108:668–676

    PubMed  Google Scholar 

  51. Chung MJ, Lee KS, Franquet T, Müller NL, Han J, Kwon OJ (2005) Metabolic lung disease: imaging and histopathologic findings. Eur J Radiol 54:233–245

    PubMed  Google Scholar 

  52. Sumikawa H, Johkoh T, Iwasawa T, Nakanishi K, Tomiyama N (2019) Pleuroparenchymal fibroelastosis-like lesions on chest computed tomography in routine clinical practice. Jpn J Radiol 37:230–236

    PubMed  Google Scholar 

  53. Delic JA, Fuhrman CR, Trejo Bittar HE (2016) Pulmonary alveolar microlithiasis: AIRP best cases in radiologic-pathologic correlation. Radiographics 36:1334–1338

    PubMed  Google Scholar 

  54. Mariotta S, Ricci A, Papale M et al (2004) Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis 21:173–181

    PubMed  Google Scholar 

  55. Sumikawa H, Johkoh T, Tomiyama N et al (2005) Pulmonary alveolar microlithiasis: CT and pathologic findings in 10 patients. Monaldi Arch Chest Dis 63:59–64

    CAS  PubMed  Google Scholar 

  56. Tseung J, Duflou J (2006) Diffuse pulmonary ossification: an uncommon incidental autopsy finding. Pathology 38:45–48

    PubMed  Google Scholar 

  57. Egashira R, Jacob J, Kokosi MA et al (2017) Diffuse pulmonary ossification in fibrosing interstitial lung diseases: prevalence and associations. Radiology 284:255–263

    PubMed  Google Scholar 

  58. Mathai SK, Schwarz MI, Ellis JH Jr (2013) Extensive diffuse pulmonary ossification after acute respiratory distress syndrome. Am J Respir Crit Care Med 187:890

    PubMed  Google Scholar 

  59. Battal B, Kocaoğlu M, Ors F, Vurucu S (2009) Massive pulmonary ossification due to recurrent aspiration pneumonia. Diagn Interv Radiol 15:212–214

    PubMed  Google Scholar 

  60. Nishioka Y, Toyoda Y, Egashira R et al (2022) Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype. BMJ Open Respir Res 9(1):e001337

    PubMed  PubMed Central  Google Scholar 

  61. Kato T, Ishikawa K, Kadoya M, Okamoto K, Kaji M (2012) Spontaneous pneumothorax in a patient with dendriform pulmonary ossification: report of a case. Surg Today 42:903–908

    PubMed  Google Scholar 

  62. Gruden JF, Green DB, Legasto AC, Jensen EA, Panse PM (2017) Dendriform pulmonary ossification in the absence of usual interstitial pneumonia: CT features and possible association with recurrent acid aspiration. AJR Am J Roentgenol 209:1209–1215

    PubMed  Google Scholar 

  63. Xu H, Yang R, Wang X, Zhu X, Chen H (2014) Symptomatic pulmonary lipiodol embolism after transarterial chemoembolization for hepatic malignant tumor: clinical presentation and chest imaging findings. Chin Med J (Engl) 127:675–679

    PubMed  Google Scholar 

  64. Chung JW, Park JH, Im JG, Han JK, Han MC (1993) Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 187:689–693

    CAS  PubMed  Google Scholar 

  65. Tajima T, Honda H, Kuroiwa T et al (2002) Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. J Vasc Interv Radiol 13:893–900

    PubMed  Google Scholar 

  66. Hatamaru K, Azuma S, Akamatsu T et al (2015) Pulmonary embolism after arterial chemoembolization for hepatocellular carcinoma: an autopsy case report. World J Gastroenterol 21:1344–1348

    PubMed  PubMed Central  Google Scholar 

  67. Narayanaswamy S, Kamath S, Williams M (2007) CT appearances of talc pleurodesis. Clin Radiol 62:233–237

    CAS  PubMed  Google Scholar 

  68. Suwatanapongched T, Nitiwarangkul C (2017) Thin-section CT findings of thoracolithiasis. Jpn J Radiol 35:350–357

    PubMed  Google Scholar 

  69. Taybi H, Capitanio MA (1990) Tracheobronchial calcification: an observation in three children after mitral valve replacement and warfarin sodium therapy. Radiology 176:728–730

    CAS  PubMed  Google Scholar 

  70. Golding LP, Walsh MJ, Sumner TE, Nakagawa TA (2013) Tracheobronchial calcifications in children. Pediatr Radiol 43:937–940

    PubMed  Google Scholar 

  71. Eckersley L, Stirling J, Occleshaw C, Wilson N (2014) Two cases of warfarin-induced tracheobronchial calcification after Fontan surgery. Pediatr Cardiol 35:954–958

    PubMed  Google Scholar 

  72. Joshi A, Berdon WE, Ruzal-Shapiro C, Barst RJ (2000) CT detection of tracheobronchial calcification in an 18-year-old on maintenance warfarin sodium therapy: cause and effect? AJR Am J Roentgenol 175:921–922

    CAS  PubMed  Google Scholar 

  73. Webb EM, Elicker BM, Webb WR (2000) Using CT to diagnose nonneoplastic tracheal abnormalities: appearance of the tracheal wall. AJR Am J Roentgenol 174:1315–1321

    CAS  PubMed  Google Scholar 

  74. Mizukami Y, Takahashi Y, Adachi H (2019) Pulmonary staple-stump granuloma after segmentectomy: two case reports and comparison with cases of stump recurrence. Am J Case Rep 20:1049–1056

    PubMed  PubMed Central  Google Scholar 

  75. Siniakowicz RM, Narula D, Suster B, Steinberg JS (2001) Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan. J Cardiovasc Electrophysiol 12:431–436

    CAS  PubMed  Google Scholar 

  76. Kuhlman JE, Teigen C, Ren H, Hruban RH, Hutchins GM, Fishman EK (1990) Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 177:121–125

    CAS  PubMed  Google Scholar 

  77. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722

    PubMed  Google Scholar 

  78. Kim HY, Song KS, Goo JM, Lee JS, Lee KS, Lim TH (2001) Thoracic sequelae and complications of tuberculosis. Radiographics 21:839–858, discussion 859-860

    CAS  PubMed  Google Scholar 

  79. Kim JS, Ryu CW, Lee SI, Sung DW, Park CK (1999) High-resolution CT findings of varicella-zoster pneumonia. AJR Am J Roentgenol 172:113–116

    CAS  PubMed  Google Scholar 

  80. Alshabani K, Ghosh S, Arrossi AV, Mehta AC (2019) Broncholithiasis: a review. Chest 156:445–455

    PubMed  Google Scholar 

  81. Asakawa K, Shimada M, Hebisawa A, Tamura A, Miyamoto M (2012) Broncholithiasis. Japanese J Chest Dis 71 supplement:S291–S295. (in Japanese)

    Google Scholar 

  82. Seo JB, Song K-S, Lee JS et al (2002) Broncholithiasis: review of the causes with radiologic-pathologic correlation. Radiographics 22:S199–S213

    PubMed  Google Scholar 

  83. Kim TS, Han J, Koh WJ et al (2005) Endobronchial actinomycosis associated with broncholithiasis: CT findings for nine patients. AJR Am J Roentgenol 185:347–353

    PubMed  Google Scholar 

  84. Lewis BT, Herr KD, Hamlin SA et al (2021) Imaging manifestations of chest trauma. Radiographics 41:1321–1334

    PubMed  Google Scholar 

  85. Kawabata Y, Watanabe A, Yamaguchi S et al (2010) Pleuropulmonary pathology of vascular Ehlers-Danlos syndrome: spontaneous laceration, haematoma and fibrous nodules. Histopathology 56:944–950

    PubMed  Google Scholar 

  86. Choe DH, Marom EM, Ahrar K, Truong MT, Madewell JE (2004) Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty. AJR Am J Roentgenol 183:1097–1102

    PubMed  Google Scholar 

  87. Duran C, Sirvanci M, Aydoğan M, Ozturk E, Ozturk C, Akman C (2007) Pulmonary cement embolism: a complication of percutaneous vertebroplasty. Acta Radiol 48:854–859

    CAS  PubMed  Google Scholar 

  88. Zhou Y, Wang XH, Meng SS et al (2020) Primary pulmonary plasmacytoma accompanied by overlap syndrome: a case report and review of the literature. World J Clin Cases 8:4999–5006

    PubMed  PubMed Central  Google Scholar 

  89. Ishida H, Fujino T, Taguchi R et al (2019) Primary pulmonary synovial sarcoma with calcification: a case report. Thorac Cancer 10:2040–2044

    PubMed  PubMed Central  Google Scholar 

  90. Marchiori E, Souza AS Jr, Franquet T, Müller NL (2005) Diffuse high-attenuation pulmonary abnormalities: a pattern-oriented diagnostic approach on high-resolution CT. AJR Am J Roentgenol 184:273–282

    PubMed  Google Scholar 

Download references

Acknowledgements

This study was partly supported by a grant from the Diffuse Lung Diseases Research Group of the Ministry of Health, Labor, and Welfare of Japan.

We thank Dr. Toru Harada of the Department of Pathology of The Jikei University School of Medicine for reviewing pathological findings, Dr. Tae Iwasawa of the Department of Radiology of Kanagawa Prefectural Cardiovascular and Respiratory Center for offering radiological images, and Dr. Akira Hebisawa of the Department of Pathology of National Hospital Organization Tokyo National Hospital for offering a pathological image. The authors would like to thank Rise Japan LLC for the professional English language review and Editage for the revised figure.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Radiology, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan

    Taiki Fukuda, Shigeki Misumi & Hiroya Ojiri

  2. Department of Radiology, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga-City, Saga, 849-8501, Japan

    Ryoko Egashira

  3. Department of Radiology, University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-Ku, Kitakyushu, Fukuoka, 807-8556, Japan

    Midori Ueno

  4. Department of Pathology, Kyushu University, 3-1-1, Maidashi, Higashi-Ku, Fukuoka-City, Fukuoka, 812-8582, Japan

    Mikiko Hashisako

  5. Department of Radiology, National Hospital Organization Kinki-Chuo Chest Medical Center, 1180, Nagasone-Cho, Kita-Ku, Sakai-City, Osaka, 591-8555, Japan

    Hiromitsu Sumikawa

  6. Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 1-1, Seiryo-Machi, Aoba-Ku, Sendai, 980-8574, Japan

    Junya Tominaga

  7. Department of Radiology, St. Luke’s International Hospital, 9-1, Akashicho, Chuo-Ku, Tokyo, 104-8560, Japan

    Daisuke Yamada

  8. Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1, Sakamoto, Nagasaki-City, Nagasaki, 852-8523, Japan

    Junya Fukuoka

  9. Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA

    Hiroto Hatabu

  10. Department of Radiology, Kansai Rosai Hospital, 3-1-69, Inabaso, Amagasaki, Hyogo, 660-8511, Japan

    Takeshi Johkoh

Authors
  1. Taiki Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryoko Egashira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Midori Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mikiko Hashisako
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiromitsu Sumikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junya Tominaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daisuke Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Junya Fukuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shigeki Misumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hiroya Ojiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hiroto Hatabu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Takeshi Johkoh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TF prepared and wrote the manuscript. TF, RE, MU, HH, and TJ revised the manuscript. TF, RE, MH, and TJ prepared figures. RE, HS, JT, DY, SM, and TJ assisted review of CT imaging features. MH assisted review of pathological findings. TF, RE, JF, HO, HH, and TJ revised the final draft. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Taiki Fukuda.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplementary Fig. S1.

Seed migration from prostate brachytherapy in an 88-year-old man. a CT image shows metallic artifact of a single seed that migrated to the right lower lobe (arrow). b Bone window image shows high punctate attenuation (arrow). Supplementary Fig. S2. Barium sulfate aspiration due to a history of nasopharyngeal carcinoma in a 55-year-old man. Bone window CT image shows barium sulfate with an obvious metallic artifact in the left lower lobe. Concurrent aspiration pneumonia is seen (arrows). Supplementary Fig. S3. Aspirated metallic dental implant in an 85-year-old man. a, b CT images show the metallic artifact of a dental implant that migrated to the right lower lobe bronchus (arrow). c Aspirated metal objects are easy to identify on the chest radiograph (arrow). Supplementary Fig. S4. Hamartoma in a 70-year-old man. a CT image shows a slightly lobulated nodule in the right lower lobe. b Mediastinal window image shows that the nodule contains focal calcification (arrows). Fat is absent. Supplementary Fig. S5. Metastatic papillary thyroid cancer in a 74-year-old man. CT image shows a soft tissue nodule with multiple nodular calcifications in the right upper lobe (arrow). Supplementary Fig. S6. Amyloidosis in a 74-year-old woman. Bone window CT image shows a mass along with the bronchovascular bundle with numerous irregular calcifications in the lingular segment (arrows), which is compatible with the nodular parenchymal type of amyloidosis. Supplementary Fig. S7. Silicosis (simple form) in a 76-year-old man. a CT image shows multiple small nodules with a perilymphatic (centrilobular and subpleural) distribution in both lungs. b Bone window image shows calcification in the nodules (arrows). Supplementary Fig. S8. Metastatic calcification in a 47-year-old man. CT image shows lobular ground-glass opacity with a centrilobular distribution. Focal dense calcification is also seen (arrows). Supplementary Fig. S9. Metastatic calcification in a 67-year-old man. Mediastinal window CT image shows dense calcification in the bilateral upper lobes. Note vascular calcification in the chest wall (arrows). Supplementary Fig. S10. Pleuroparenchymal fibroelastosis (PPFE)-like lesion in a 64-year-old male. Bone window CT image shows subpleural opacities with high punctate attenuation (arrows). Histopathology reveals calcification and ossification in the subpleural fibroelastosis. Supplementary Fig. S11. Secondary diffuse pulmonary ossification due to acute respiratory distress syndrome (ARDS) in a 75-year-old man. a CT image shows mixed coarse and fine reticulation with subpleural predominance in the left upper lobe. b Bone window image shows high-attenuation nodules in the area of coarse reticulation (arrows). High-attenuation nodules gradually increased during a 2-year period after suffering from ARDS. Supplementary Fig. S12. Idiopathic dendriform pulmonary ossification in a 65-year-old man. a CT image shows the lattice-like distribution of multiple linear and nodular opacities in the peripheral area of the lung bases. b Bone window CT image shows numerous high-attenuation small linear and branching structures (arrows). c Volume rendering image of the lungs. Bony lesions are shown as yellow color structures. d Magnified volume rendering image of the right lower lobe. Dendriform and coral-like shapes of bony structures are shown. Supplementary Fig. S13. Thoracolithiasis in a 50-year-old man. a, b Initial CT images show a smooth-marginated calcified nodule (arrow). c, d Follow-up CT images obtained eight years later show migration of the calcified nodule into the posteroinferior region (arrow). Supplementary Fig. S14. Tracheobronchial amyloidosis in a 22-year-old woman. CT image shows bronchial wall thickening with calcification (arrows). Supplementary Fig. S15. Postoperative status of pneumothorax in a 65-year-old man. Bone window CT image shows high-attenuation linear structures that abut the pleura, which correspond to surgical staples, are seen (arrows). Supplementary Fig. S16. Inactive tuberculosis in a 70-year-old man. CT image shows linear calcification in the right upper lobe, adjacent to the bulla (arrows). Supplementary Fig. S17. Inactive tuberculosis in a 90-year-old man. CT image shows numerous calcified nodules associated with soft tissues (arrows). Supplementary Fig. S18. Ghon focus in a 60-year-old man. CT image shows nodular calcification in the periphery of the right lower lobe (arrow). Supplementary Fig. S19. Broncholithiasis in a 58-year-old woman. Photomicrograph (original magnification, × 10; decalcified H-E stain) depicts a concentric decalcified stone that is considered to have originated from mucus. Supplementary Fig. S20. Broncholithiasis in a 71-year-old man. CT image shows a calcified nodule within a dilated bronchus near the left hilum (arrow). Calcified lymph nodes at the left hilum and mediastinum are also shown (arrowheads). Supplementary Fig. S21. Cement migration due to percutaneous vertebroplasty in a 77-year-old woman. a CT scout view shows post-multilevel vertebroplasty (arrows). b Postoperative bone window CT image shows cement migration to the left lower lobe (arrow).

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fukuda, T., Egashira, R., Ueno, M. et al. Stepwise diagnostic algorithm for high-attenuation pulmonary abnormalities on CT. Insights Imaging 14, 177 (2023). https://doi.org/10.1186/s13244-023-01501-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13244-023-01501-x

Keywords